CAVR (n = 11) | TAVI (n = 11) | p-value | |
---|---|---|---|
Age [yrs] | 69.0 ± 11.2 | 81.0 ± 4.8 | 0.004 |
Female [N] | 5 (45.5%) | 7 (63.6%) | 0.670 |
Height [cm] | 175.6 ± 5.0 | 166.2 ± 9.2 | 0.011 |
Weight [kg] | 84.9 ± 11.6 | 65.5 ± 12.4 | 0.002 |
Log. euroSCORE | 5.33 ± 4.40 | 19.37 ± 7.05 | <0.001 |
STS score | 1.90 ± 1.06 | 7.85 ± 3.59 | <0.001 |
CAD [N] | 4 (36.4%) | 8 (72.7%) | 0.198 |
Pre-operative creatinine [mg/dL] | 0.92 ± 0.2 | 1.52 ± 0.9 | 0.042 |
Pre-operative hemoglobin [g/dL] | 13.8 ± 1.3 | 11.6 ± 0.9 | 0.001 |
Pre-operative CK [U/L] | 63.8 ± 24.7 | 42.0 ± 27.1 | 0.053 |
Pre-operative CK-MB [U/L] | 6.73 ± 1.6 | 10.36 ± 5.6 | 0.053 |
Pre-operative Troponin T [μg/L] | 0.01 ± 0.01 | 0.08 ± 0.10 | 0.031 |
Pre-operative EF [%] | 61.9 ± 23.1 | 49.9 ± 26.0 | 0.355 |
Pre-operative AVA [cm2] | 0.62 ± 0.30 | 0.60 ± 0.22 | 0.922 |
Pre-operative cardiac decompensation [N] | 0 | 4 (36.4%) | 0.045 |
Arterial hypertension [N] | 10 (90.9%) | 11 (100.0%) | 1.000 |
Hyperlipoproteinemia [N] | 10 (90.9%) | 11 (100.0%) | 1.000 |
Pre-operative pulmonary hypertension [N] | 0 | 2 (18.2%) | 0.476 |
Previous statin therapy [N] | 10 (90.9%) | 11 (100.0%) | 1.000 |
History of AMI [N] | 0 | 1 (9.1%) | 0.168 |